Laboratory Corp of America Holdings (LH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 492,100 | 2,379,500 | 1,825,900 | 1,238,100 | 770,100 |
| Depreciation Amortization | 162,700 | 577,000 | 557,100 | 371,000 | 183,900 |
| Income taxes - deferred | -19,000 | -37,300 | -102,000 | -85,500 | -27,800 |
| Accounts receivable | -64,100 | 226,300 | -50,300 | 164,700 | 104,200 |
| Accounts payable and accrued liabilities | -5,500 | -5,300 | 34,600 | -44,300 | -16,900 |
| Other Working Capital | -363,300 | -187,900 | -84,800 | -30,000 | 157,600 |
| Other Operating Activity | 153,100 | 157,300 | 231,600 | 30,800 | -13,500 |
| Operating Cash Flow | $356,000 | $3,109,600 | $2,412,100 | $1,644,800 | $1,157,600 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -27,800 | 10,400 | N/A | N/A |
| PPE Investments | -116,200 | -334,200 | -306,900 | -189,900 | -92,800 |
| Net Acquisitions | -455,100 | -496,900 | -313,600 | -21,000 | -34,100 |
| Purchase Of Investment | -2,200 | N/A | -20,000 | -11,900 | -5,500 |
| Sale Of Investment | 400 | 13,200 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -38,900 | 0 | 0 | 0 |
| Investing Cash Flow | $-573,100 | $-884,600 | $-630,100 | $-222,800 | $-132,400 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,000,000 | 1,000,000 | 1,000,000 | N/A |
| Debt Repayment | N/A | -1,375,000 | -1,375,000 | -1,375,000 | -375,000 |
| Common Stock Issued | 18,200 | 51,700 | 50,800 | 26,600 | 24,700 |
| Common Stock Repurchased | N/A | -1,668,500 | -668,500 | -368,500 | -68,500 |
| Other Financing Activity | -35,900 | -74,000 | -64,500 | -58,600 | -31,300 |
| Financing Cash Flow | $-17,700 | $-2,065,800 | $-1,057,200 | $-775,500 | $-450,100 |
| Exchange Rate Effect | -4,400 | -7,300 | -9,100 | -4,100 | -5,100 |
| Beginning Cash Position | 1,472,700 | 1,229,500 | 1,320,800 | 1,320,800 | 1,320,800 |
| End Cash Position | 1,233,500 | 1,381,400 | 2,036,500 | 1,963,200 | 1,890,800 |
| Net Cash Flow | $-239,200 | $151,900 | $715,700 | $642,400 | $570,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 356,000 | 3,109,600 | 2,412,100 | 1,644,800 | 1,157,600 |
| Capital Expenditure | -117,200 | -421,500 | -310,400 | -192,600 | -95,400 |
| Free Cash Flow | 238,800 | 2,688,100 | 2,101,700 | 1,452,200 | 1,062,200 |